[1st EAGOT Annual Meeting 2023 in Niigata]

JGOG2051/KGOG2031:

Phase II trial of repeated high dose luteal hormone therapy for intrauterine recurrence following fertility preserving therapy for atypical endometrial hyperplasia or endometrial cancer

presented by Kensuke Sakai/Wataru Yamagami (JGOG)